A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension

Clinical trial NCT06168409 · COMPLETED

Trial details

NCT number: NCT06168409
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Resistant Hypertension

Start date: 2024-03-01
Primary completion: 2025-08-17
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.